Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2020 / N 3

Лекарственно-индуцированный панкреатит
О.Д. Остроумова, В.О. Качан

Список литературы

1. Министерство здравоохранения РФ; Российское общество хирургов; Ассоциация гепатопанкреатобилиарных хирургов стран СНГ. Клинические рекомендации. Острый панкреатит. МКБ 10: K85.0 /K85.1/ K85.2 /K85.3/ K85.8 /K85.9. Год утверждения (частота пересмотра): 2015 (пересмотр каждые 5 лет). ID: КР326. Доступно по: https://www.mrckb.ru/files/ostryj_pankreatit.pdf Ссылка активна на 07.12.2020.
2. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. Journal of Clinical Gastroenterology 2005 Sep;39(8):709-16.
3. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Alimentary Pharmacology & Therapeutics 2003 Apr;17(7):887-93.
4. Fathallah N, Slim R, Larif S, Hmouda H, Sakhri J, Ben Salem C. Drug-induced acute pancreatitis confirmed by positive re-challenge. Pancreatic Disorders & Therapy 2015 Sep;5:S6.
5. Ивашкин В.Т. Горизонты клинической гастроэнтерологии. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 1993;1:4-12.
6. Etemad  B,  Whitcomb  DC.  Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001 Feb;120(3):682-707.
7. Drug-induced diseases: prevention, detection, and management. Tisdale JE, Miller DA, editors. 3rd ed. Bethesda, Md.: American Society of Health-System Pharmacists; 2018. 1400 p.
8. Nitsche C, Maertin S, Scheiber J, Ritter CA, Lerch MM, Mayerle J. Drug-induced pancreatitis. Current Gastroenterology Reports 2012 Apr;14(2):131-8.
9. Underwood TW, Frye CB. Drug-induced pancreatitis. Clinical Pharmacy 1993 Jun;12(6):440-8.
10. Lai SW, Wang YC, Wang CH, Huang TY. Acute pancreatitis and erythema nodosum associated with azathioprine. QJM 2012 Apr;105(4):363-4.
11. Halalsheh H, Bazzeh F, Alkayed K, Salami K, Madanat F. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma. Journal of Pediatric Hematology/Oncology 2013 Aug;35(6):470-2.
12. Standridge JB. Fulminant pancreatitis associated with lisinopril therapy. Southern Medical Journal 1994 Feb;87(2):179-81.
13. Banerjee AK, Patel KJ, Grainger SL. Drug-induced acute pancreatitis. Medical Toxicology and Adverse Drug Experience 1989;4(3):186-98.
14. Jones MR, Hall OM, Kaye AM, Kaye AD. Drug-induced acute pancreatitis: a review. The Ochsner Journal 2015 Spring;15(1):45-51.
15. Asghar MU, Cheema HA, Tanveer K, Leinwand J. Propofol infusion and acute pancreatitis: a review. American Journal of Therapeutics 2020 Jul-Aug;27(4):e371-4.
16. Kikuchi I, Miyata N, Yoshimura Y, Miyamoto K, Tachikawa N. Methimazole-induced acute pancreatitis: a case report. Clinical Journal of Gastroenterology 2019 Jun;12(3):239-42.
17. Longhurst HJ, Pinching AJ. Drug points: pancreatitis associated with hydroxyurea in combination with didanosine. BMJ 2001 Jan;322(7278):81.
18. Callens S, De Schacht C, Huyst V, Colebunders R. Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment. The Journal of Infection 2003 Aug;47(2):188-9.
19. Foisy MM, Slayter KL, Hewitt RG, Morse GD. Pancreatitis during intravenous pentamidine therapy in an AIDS patient with prior exposure to didanosine. The Annals of Pharmacotherapy 1994 Sep;28(9):1025-8.
20. Ranson JH, Rifkind KK, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surgery, Gynecology, Obstetrics 1974 Jul Jul;139(1):69-81.
21. Bolesta S, Montgomery P. Pancreatitis. In: Pharmacotherapy: a pathophysiologic approach. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. 9th ed. New York, NY: McGraw-Hill Medical; 2014: 721-36.
22. Ksiądzyna D. Drug-induced acute pancreatitis related to medications commonly used in gastroenterology. European Journal of Internal Medicine 2011 Feb;22(1):20-5.
23. Cooper ST, Slivka A. Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterology Clinics of North America 2007 Jun;36(2):259-76, vii-viii.
24. Сычев Д.А., Остроумова О.Д., Переверзев А.П., Кочетков А.И., Остроумова Т.М., Клепикова М.В., Аляутдинова И.А., Голобородова И.В. Лекарственно-индуцированные заболевания: подходы к диагностике, коррекции и профилактике. Фармаконадзор. Фарматека 2020;27(6):113-26.
25. Lanctôt KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clinical Pharmacology & Therapeutics 1995 Dec;8(6):692-8.
26. Borgia MC, Celestini A, Caravella P, Catalano C. Angiotensin-converting-enzyme inhibitor administration must be monitored for serum amylase and lipase in order to prevent an acute pancreatitis: a case report. Angiology 2001 Sep;52(9):645-7.
27. Lankisch PG, Werner HM. Mirtazapine: another drug responsible for drug-induced acute pancreatitis? A letter of warning. Pancreas 2003 Mar;26(2):211.
28. Pratt CB, Simone JV, Zee P, Aur RJ, Johnson WW. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. The Journal of Pediatrics 1970 Sep;77(3):474-83.
29. Nguyen DL, Wilson DA, Engelman ED, Sexauer CL, Nitschke R. Serial sonograms to detect pancreatitis in children receiving L-asparaginase. Southern Medical Journal 198 Sep;80(9):1133-6.

References

1. Ministry of Healthcare of the Russian Federation; Russian Society of Surgeons; Hepato-Pancreato-Biliary Association of Commonwealth of Independent States. Clinical recommendations. Acute pancreatitis. ICD 10: K85. 0 /K85. 1/ K85.2 /K85.3/ K85.8 /K85.9. Year of approval (frequency of review): 2015 (review every 5 years). ID: KR326. Available from: https://www.mrckb.ru/files/ostryj_pankreatit.pdf Accessed 2020 Dec 07. (In Russian).
2. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. Journal of Clinical Gastroenterology 2005 Sep;39(8):709-16.
3. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Alimentary Pharmacology & Therapeutics 2003 Apr;17(7):887-93.
4. Fathallah N, Slim R, Larif S, Hmouda H, Sakhri J, Ben Salem C. Drug-induced acute pancreatitis confirmed by positive re-challenge. Pancreatic Disorders & Therapy 2015 Sep;5:S6.
5. Ivashkin VT. Horizons of clinical gastroenterology. Russian Journal of Gastroenterology, Hepatology, Coloproctology 1993;1:4-12 (In Russian).
6. Etemad  B,  Whitcomb  DC.  Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001 Feb;120(3):682-707.
7. Drug-induced diseases: prevention, detection, and management. Tisdale JE, Miller DA, editors. 3rd ed. Bethesda, Md.: American Society of Health-System Pharmacists; 2018. 1400 p.
8. Nitsche C, Maertin S, Scheiber J, Ritter CA, Lerch MM, Mayerle J. Drug-induced pancreatitis. Current Gastroenterology Reports 2012 Apr;14(2):131-8.
9. Underwood TW, Frye CB. Drug-induced pancreatitis. Clinical Pharmacy 1993 Jun;12(6):440-8.
10. Lai SW, Wang YC, Wang CH, Huang TY. Acute pancreatitis and erythema nodosum associated with azathioprine. QJM 2012 Apr;105(4):363-4.
11. Halalsheh H, Bazzeh F, Alkayed K, Salami K, Madanat F. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma. Journal of Pediatric Hematology/Oncology 2013 Aug;35(6):470-2.
12. Standridge JB. Fulminant pancreatitis associated with lisinopril therapy. Southern Medical Journal 1994 Feb;87(2):179-81.
13. Banerjee AK, Patel KJ, Grainger SL. Drug-induced acute pancreatitis. Medical Toxicology and Adverse Drug Experience 1989;4(3):186-98.
14. Jones MR, Hall OM, Kaye AM, Kaye AD. Drug-induced acute pancreatitis: a review. The Ochsner Journal 2015 Spring;15(1):45-51.
15. Asghar MU, Cheema HA, Tanveer K, Leinwand J. Propofol infusion and acute pancreatitis: a review. American Journal of Therapeutics 2020 Jul-Aug;27(4):e371-4.
16. Kikuchi I, Miyata N, Yoshimura Y, Miyamoto K, Tachikawa N. Methimazole-induced acute pancreatitis: a case report. Clinical Journal of Gastroenterology 2019 Jun;12(3):239-42.
17. Longhurst HJ, Pinching AJ. Drug points: pancreatitis associated with hydroxyurea in combination with didanosine. BMJ 2001 Jan;322(7278):81.
18. Callens S, De Schacht C, Huyst V, Colebunders R. Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment. The Journal of Infection 2003 Aug;47(2):188-9.
19. Foisy MM, Slayter KL, Hewitt RG, Morse GD. Pancreatitis during intravenous pentamidine therapy in an AIDS patient with prior exposure to didanosine. The Annals of Pharmacotherapy 1994 Sep;28(9):1025-8.
20. Ranson JH, Rifkind KK, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surgery, Gynecology, Obstetrics 1974 Jul Jul;139(1):69-81.
21. Bolesta S, Montgomery P. Pancreatitis. In: Pharmacotherapy: a pathophysiologic approach. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. 9th ed. New York, NY: McGraw-Hill Medical; 2014: 721-36.
22. Ksiądzyna D. Drug-induced acute pancreatitis related to medications commonly used in gastroenterology. European Journal of Internal Medicine 2011 Feb;22(1):20-5.
23. Cooper ST, Slivka A. Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterology Clinics of North America 2007 Jun;36(2):259-76, vii-viii.
24. Sychev DA, Ostroumova OD, Pereverzev AP, Kochetkov AI, Ostroumova TM, Klepikova MV, Alyautdinova IA, Goloborodova IV. Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance. Farmateka 2020;27(6):113-26 (In Russian).
25. Lanctôt KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clinical Pharmacology & Therapeutics 1995 Dec;8(6):692-8.
26. Borgia MC, Celestini A, Caravella P, Catalano C. Angiotensin-converting-enzyme inhibitor administration must be monitored for serum amylase and lipase in order to prevent an acute pancreatitis: a case report. Angiology 2001 Sep;52(9):645-7.
27. Lankisch PG, Werner HM. Mirtazapine: another drug responsible for drug-induced acute pancreatitis? A letter of warning. Pancreas 2003 Mar;26(2):211.
28. Pratt CB, Simone JV, Zee P, Aur RJ, Johnson WW. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. The Journal of Pediatrics 1970 Sep;77(3):474-83.
29. Nguyen DL, Wilson DA, Engelman ED, Sexauer CL, Nitschke R. Serial sonograms to detect pancreatitis in children receiving L-asparaginase. Southern Medical Journal 198 Sep;80(9):1133-6.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]